https://www.selleckchem.com/pr....oducts/o6-benzylguan
Six RCTs and eight non-RCTs were included. In total, 821 patients with SqCLC were included. The response rate (RR) was 2.12 (95% CI 1.57-2.85, p 0.00001). The disease control rate (DCR) was 2.38 (95% CI 1.70-3.32, p 0.00001). The difference between the two groups was statistically significant. Regarding safety, the incidence rates of the adverse reactions cardiotoxicity, leukopenia, thrombocytopenia, and gastrointestinal reactions were not significantly different between the two groups (OR = 1.70, 95% CI 0.79-3.68; OR
Like
Comment
Share
